Solid Biosciences Inc (SLDB)

Shares of Solid Biosciences (SLDB) dropped by 5.51% from $2.72 to $2.57 in the trading on Friday, Novemeber 17, 2023. The reason why SLDB is down today is due to recent announcement from the company. Solid Biosciences announced that it had received FDA clearance for an Investigational New Drug (IND) application for its gene therapy candidate aimed at treating Duchenne muscular dystrophy. Despite this positive development, the stock price declined, possibly reflecting investor sentiment or broader market dynamics.

Shares of Solid Biosciences (SLDB) dropped by 5.51% from $2.72 to $2.57 in the trading on Friday, Novemeber 17, 2023. The reason why SLDB is down today is due to recent announcement from the company. Solid Biosciences announced that it had received FDA clearance for an Investigational New Drug (IND) application for its gene therapy candidate aimed at treating Duchenne muscular dystrophy. Despite this positive development, the stock price declined, possibly reflecting investor sentiment or broader market dynamics.